0.95
cbdMD Inc stock is traded at $0.95, with a volume of 21,472.
It is up +2.15% in the last 24 hours and up +9.20% over the past month.
See More
Previous Close:
$0.93
Open:
$0.96
24h Volume:
21,472
Relative Volume:
0.20
Market Cap:
$8.46M
Revenue:
$23.45M
Net Income/Loss:
$-19.98M
P/E Ratio:
-0.0752
EPS:
-12.63
Net Cash Flow:
$-2.65M
1W Performance:
-1.66%
1M Performance:
+9.20%
6M Performance:
-79.87%
1Y Performance:
-80.25%
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
YCBD
cbdMD Inc
|
0.95 | 8.28M | 23.45M | -19.98M | -2.65M | -12.63 |
![]()
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
cbdMD Inc Stock (YCBD) Latest News
Is cbdMD Inc. a good long term investmentExceptional profit velocity - Autocar Professional
cbdMD Inc. Stock Analysis and ForecastPowerful market insights - PrintWeekIndia
What analysts say about cbdMD Inc. stockOutperformance with explosive growth - jammulinksnews.com
What drives cbdMD Inc. stock priceHigh-yield investments - jammulinksnews.com
How cbdMD Inc. stock performs during market volatilityFree Market Analysis Group - Newser
What makes cbdMD Inc. stock price move sharplyExpert Backed Predictions - Newser
Why cbdMD Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser
Cbd Gummies Vs Xanax : How to Choose the Best CBD Gummies - Appalachian Voices
cbdMD (NYSEAMERICAN:YCBD) Shares Down 6.4% – Should You Sell? - Defense World
cbdMD Expands Oasis Social Tonics to Total Wine - Newsfile
cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Update - Defense World
cbdMD CBD PM Sleep Aid Review - Sleepopolis
Sibyl Swift, Ph.D., Chief Science Officer & VP of Regulatory Affairs, cbdMD - WholeFoods Magazine
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter - Newsfile
cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile
Maxim Group Cuts cbdMD (NYSEAMERICAN:YCBD) Price Target to $3.00 - Defense World
cbdMD (YCBD) Maintains Buy Rating Despite Lowered Price Target | - GuruFocus
cbdMD (YCBD) Maintains Buy Rating Despite Lowered Price Target | YCBD Stock News - GuruFocus
cbdMD (YCBD) Price Target Slashed Due to Earnings Miss | YCBD St - GuruFocus
cbdMD price target lowered to $3 from $16 at Maxim - TipRanks
Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia - TradingView
THC Beverage Leader Herbal Oasis Captures $571M Market With Major Southeast Expansion - Stock Titan
cbdMD grants restricted stock units to directors By Investing.com - Investing.com India
cbdMD grants restricted stock units to directors - Investing.com
cbdMD Issues Restricted Stock Units to Directors - TipRanks
cbdMD's Q2 2025: Unpacking Contradictions in Herbal Oasis Growth, Cash Burn, and Financial Strategy - AInvest
cbdMD, Inc. (AMEX:YCBD) Q2 2025 Earnings Call Transcript - Insider Monkey
CbdMD, Inc. Earnings Call: Restructuring and Growth Prospects - TipRanks
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):